Dossier Evaluation status

Dossier Evaluation status

Data platform availability banner - dossier evaluation status

The new ECHA CHEM database has been released by ECHA. See for more information on the transition to ECHA CHEM.  More

Please be aware that REACH registration data on the current Dissemination Platform (accessible through the magnifying glass icon in the table) is no longer maintained; it remains frozen as of 19th May 2023. As shown in the support page we hope to move the dossier evaluation information to ECHA CHEM by the end of 2024. Until then, while the assessment status will be updated here, the corresponding registration dossiers will be available only on ECHA CHEM.

We appreciate your understanding during this transition period.


 

Dossier Evaluation status

ECHA’s dossier evaluation process covers compliance checks and the examination of testing proposals. By consulting the table below, you can find out whether ECHA has started to evaluate dossiers for a particular substance and follow the progress through the evaluation process.

The table below displays the type, scope and status of the assessment undertaken for a given dossier. The decision date and the non-confidential version of the decision are published shortly after the decision has been adopted.

Before publishing the non-confidential version of an adopted decision on its website, ECHA consults the addressees of the decision on this version. ECHA systematically removes any personal data from the non-confidential version of a decision. Some sections may also be redacted based on justified claims by registrants, regarding information confidential or deemed to harm their commercial interest if disclosed.

Check the expandable boxes below for more details.

 

Content of the table

Identifiers of the substance: Name (as on the Dissemination website); EC/List number (European Community number / List number assigned by ECHA); CAS number (also called the Chemical Abstract Service Registry Number or CAS RN).

Decision type can be ‘CCH’ for Compliance Check Evaluation and ‘TPE’ for Testing Proposal Evaluation.

Scope refers to the scope of the evaluation and can be:

  • Targeted: The compliance check focuses only on some endpoints.
  • Comprehensive: The compliance check focuses on all relevant endpoints under ECHA’s strategy.
  • Testing proposal: The assessment focuses on the testing proposals submitted by the registrants.

Status reports the current position of the dossier in the dossier evaluation process and can be:

  • Under assessment: The evaluation of the dossier has formally started.
  • Ongoing: The registrants have received the draft decision - The dossier retains this status until the decision is adopted or the evaluation is otherwise concluded.
  • Information requested: The registrants have received the adopted decision with the deadline for providing the requested information.
  • Follow-up: The deadline set in the adopted decision has passed, and ECHA is assessing whether the information requested in the decision has been provided in the dossier update - This follow-up may also involve the national enforcement authorities.
  • Concluded: The evaluation is closed.
    In most cases, this means that the registrant has responded to the adopted decision with compliant information. However, as in some cases an evaluation is concluded at an earlier stage, an adopted decision is not always available for every evaluation marked as concluded.

Decision date reports the date on which the adopted decision was sent to the registrants.

Decision displays a non-confidential version of the adopted decision once available.

Latest update indicates the date of the latest automatic update carried out by ECHA’s information systems.

Unless confidentiality is claimed on the substance identifiers, you can access the disseminated registration dossiers for the substance in ECHA CHEM. From the table below, click on the substance name link to access the Substance Infocard. From there you will find a link to direct you to the ECHA CHEM substance Dashboard and the REACH registration dossier(s). You can also go directly to ECHA CHEM and search with substance identifiers. 

The magnifying glass icon leads to information on the current dissemination platform that has not been updated since May 2023. We apologise for the inconvenience and appreciate your understanding during the transition period. 

You can access additional information in ‘Details’ view, by clicking on the eye icon:

  • Substance identifiers
  • Decision type (CCH or TPE), scope and status of the evaluation, as in the main table
  • Decision’s deadline(s): The deadline(s) for requested information contained in the decision, should the decision contain more than one deadline
  • Appeal information: If the registrants have appealed against the adopted decision, a link to the Board of Appeal’s announcement document is provided.

 

How to read the table

ECHA’s information systems automatically update the status of dossier evaluations during the process. For transparency reasons, all dossier evaluation decisions will remain published. This also applies if the registrants have appealed or have updated the registration dossier as requested in the decision.

It is for the reader to verify the status of an evaluation: check the deadline of the decision, the indicated status of the evaluation, and the content of the registration dossier. The most recent registration data on a substance is available in the ECHA CHEM database; check also whether the Board of Appeal has taken a decision regarding any appeal.

 

Important notes:

  • The dossier evaluation decisions may not apply to all registrants that are part of a joint registration.
  • There may be a delay between the decision date and the actual publication of the adopted decision, which corresponds to the consultation on its non-confidential version and addressing any comments from the registrants.
Last updated 12 April 2024. Database contains 4162 unique substances/entries.
Filter the list
Decision's deadline:
Decision date:

The List does not contain any Substances.
Decision    
ESACURE KIP 100; ESACURE KIP 150
402-990-3
163702-01-0
CCH
Comprehensive
Ongoing
12-Apr-2024
Details
240-505-5
16455-61-1
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
434-430-9
-
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
938-828-8
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
941-883-0
-
CCH
Comprehensive
Follow-up
11-Jan-2023
11-Apr-2024
View
Details
904-551-6
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
943-653-5
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
293-615-0
91081-13-9
CCH
Comprehensive
Ongoing
11-Apr-2024
View
Details
240-715-7
16669-59-3
CCH
Comprehensive
Ongoing
11-Apr-2024
View
Details
227-193-6
5704-04-1
CCH
Comprehensive
Concluded
11-Apr-2024
View
Details
222-871-8
3644-11-9
CCH
Comprehensive
Ongoing
11-Apr-2024
View
Details
245-950-9
23949-66-8
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
203-755-6
110-30-5
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
203-897-9
111-70-6
CCH
Comprehensive
Concluded
06-Sep-2021
11-Apr-2024
View
Details
242-604-9
18824-74-3
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
213-537-2
971-15-3
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
204-331-3
119-53-9
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
953-736-8
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
953-735-2
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
462-490-6
-
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
828-479-9
2088841-41-0
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
KEROFLUX ES 3241
406-640-0
136920-07-5
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
240-759-7
16712-64-4
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
204-841-6
127-41-3
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
238-969-9
14901-07-6
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
204-846-3
127-51-5
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
257-288-8
51566-62-2
CCH
Targeted
Information requested
13-Feb-2024
11-Apr-2024
View
Details
246-386-6
24650-42-8
CCH
Comprehensive
Ongoing
11-Apr-2024
View
Details
429-750-0
180898-37-7
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
278-928-2
78491-02-8
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
423-300-7
911674-82-3
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
257-913-4
52434-90-9
CCH
Comprehensive
Information requested
13-Feb-2024
11-Apr-2024
View
Details
215-304-0
1320-51-0
CCH
Comprehensive
Under assessment
11-Apr-2024
View
Details
201-224-3
79-77-6
CCH
Targeted
Under assessment
11-Apr-2024
View
Details
232-077-3
7785-26-4
TPE
Testing Proposal
Concluded
23-Nov-2018
11-Apr-2024
View
Details
404-290-3
7216-95-7
TPE
Testing Proposal
08-Apr-2024
View
Details
220-237-5
2680-03-7
TPE
Testing Proposal
Under assessment
08-Apr-2024
View
Details
239-263-3
15206-55-0
TPE
Testing Proposal
Concluded
08-Apr-2024
View
Details
230-794-6
7321-53-1
CCH
Comprehensive
Ongoing
08-Apr-2024
View
Details
204-260-8
118-56-9
TPE
Testing Proposal
Under assessment
08-Apr-2024
View
Details
235-384-0
12207-63-5
TPE
Testing Proposal
Under assessment
08-Apr-2024
View
Details
241-753-7
17772-51-9
TPE
Testing Proposal
08-Apr-2024
View
Details
204-263-4
118-60-5
TPE
Testing Proposal
Under assessment
08-Apr-2024
View
Details
701-514-4
-
TPE
Testing Proposal
08-Apr-2024
View
Details
613-333-7
63705-03-3
TPE
Testing Proposal
Under assessment
08-Apr-2024
View
Details
231-545-4
7631-86-9
CCH
Targeted
Follow-up
22-Jun-2023
05-Apr-2024
View
Details
231-545-4
7631-86-9
CCH
Targeted
Follow-up
22-Jun-2023
05-Apr-2024
View
Details
206-156-8
304-59-6
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
206-156-8
304-59-6
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
212-769-1
868-14-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
212-769-1
868-14-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
212-769-1
868-14-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
212-769-1
868-14-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
214-426-1
1126-79-0
CCH
Comprehensive
Follow-up
27-Jun-2022
05-Apr-2024
View
Details
936-414-1
-
CCH
Targeted
Follow-up
22-Jun-2023
05-Apr-2024
View
Details
421-140-2
-
CCH
Comprehensive
Concluded
05-Apr-2024
View
Details
953-917-1
-
TPE
Testing Proposal
Follow-up
23-Mar-2022
05-Apr-2024
View
Details
213-067-8
921-53-9
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
203-957-4
112-31-2
CCH
Comprehensive
Follow-up
27-Jun-2022
05-Apr-2024
View
Details
627-085-2
1238449-42-7
CCH
Comprehensive
Concluded
05-Apr-2024
View
Details
221-621-5
3164-34-9
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
201-766-0
87-69-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
201-766-0
87-69-4
CCH
Comprehensive
Follow-up
24-Jun-2021
05-Apr-2024
View
Details
700-676-3
135452-42-5
CCH
Comprehensive
Ongoing
04-Apr-2024
View
Details
696-038-6
135452-43-6
CCH
Comprehensive
Ongoing
04-Apr-2024
View
Details
429-040-0
272460-97-6
CCH
Comprehensive
Ongoing
04-Apr-2024
View
Details
293-883-9
91648-24-7
TPE
Testing Proposal
Concluded
03-Nov-2021
04-Apr-2024
View
Details
269-825-3
68334-35-0
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
941-198-7
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-444-4
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-485-8
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-521-2
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
446-220-4
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
915-748-1
-
TPE
Testing Proposal
Follow-up
21-Jun-2022
03-Apr-2024
View
Details
700-950-2
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
915-673-4
-
TPE
Testing Proposal
Follow-up
21-Jun-2022
03-Apr-2024
View
Details
947-805-1
213077-23-7
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
274-986-8
70892-34-1
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
202-163-5
92-52-4
CCH
Comprehensive
Ongoing
03-Apr-2024
View
Details
701-486-3
-
CCH
Comprehensive
Concluded
03-Apr-2024
View
Details
701-512-3
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-499-4
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-499-4
-
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
701-522-8
1153-34-0
CCH
Targeted
Under assessment
03-Apr-2024
View
Details
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Illicium verum, Illiciaceae.
283-518-1
84650-59-9
TPE
Testing Proposal
Follow-up
15-Jun-2022
28-Mar-2024
View
Details
255-288-2
41272-40-6
CCH
Comprehensive
Follow-up
03-Nov-2023
28-Mar-2024
View
Details
255-288-2
41272-40-6
CCH
Comprehensive
Follow-up
17-Sep-2021
28-Mar-2024
View
Details
266-369-7
66469-15-6
CCH
Comprehensive
Ongoing
27-Mar-2024
View
Details
950-068-9
-
CCH
Comprehensive
Information requested
18-Apr-2023
26-Mar-2024
View
Details
213-537-2
971-15-3
CCH
Comprehensive
Concluded
10-Nov-2017
26-Mar-2024
View
Details
280-041-0
82799-44-8
CCH
Comprehensive
Concluded
26-Mar-2024
View
Details
An inorganic pigment that is the reaction product of high temperature calcination in which praseodymium (III) oxide, praseodymium (IV) oxide, silicon oxide, and zirconium (IV) oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of zircon. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
269-075-7
68187-15-5
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
An inorganic pigment that is the reaction product of high temperature calcination in which praseodymium (III) oxide, praseodymium (IV) oxide, silicon oxide, and zirconium (IV) oxide in varying amounts are homogeneously and ionically interdiffused to form a crystalline matrix of zircon. Its composition may include any one or a combination of the modifiers alkali or alkaline earth halides.
269-075-7
68187-15-5
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
1 - 6.5 moles propoxylated
500-105-6
39423-51-3
TPE
Testing Proposal
Ongoing
25-Mar-2024
View
Details
231-760-3
7722-64-7
CCH
Comprehensive
Concluded
11-May-2020
25-Mar-2024
View
Details
209-676-3
590-28-3
TPE
Testing Proposal
Concluded
05-Apr-2019
25-Mar-2024
View
Details
264-438-6
63738-22-7
TPE
Testing Proposal
Concluded
17-Mar-2021
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77005.
269-061-0
68186-99-2
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77005.
269-061-0
68186-99-2
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
701-304-2
-
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
701-304-2
-
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
An inorganic pigment that is the reaction product of high temperature calcination of principally chromium (III) oxide forming a crystalline hematite. Its composition may include any one or a combination of the modifiers Al2O3, Fe2O3, or Mn2O3.
272-713-7
68909-79-5
CCH
Targeted
Concluded
20-Apr-2016
25-Mar-2024
View
Details
292-947-3
91031-45-7
CCH
Comprehensive
Ongoing
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77347.
269-049-5
68186-87-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
This substance is identified in the Colour Index by Colour Index Constitution Number, C.I. 77347.
269-049-5
68186-87-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
235-790-8
12737-27-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
235-790-8
12737-27-8
CCH
Targeted
Concluded
25-Sep-2019
25-Mar-2024
View
Details
231-146-5
7440-36-0
TPE
Testing Proposal
Concluded
25-Mar-2024
View
Details
This substance is identified by SDA Substance Name: C12-C18 alkyl dimethyl amine and SDA Reporting Number: 16-040-00.
269-923-6
68391-04-8
CCH
Comprehensive
Concluded
08-Feb-2022
25-Mar-2024
View
Details
288-293-3
85711-34-8
CCH
Comprehensive
Ongoing
25-Mar-2024
View
Details
252-068-8
34513-98-9
TPE
Testing Proposal
Follow-up
14-Jun-2022
22-Mar-2024
View
Details
241-164-5
17095-24-8
CCH
Targeted
Under assessment
22-Mar-2024
View
Details
284-698-4
84962-05-0
CCH
Comprehensive
Ongoing
22-Mar-2024
View
Details
251-118-6
32588-76-4
CCH
Targeted
Information requested
23-Jan-2024
22-Mar-2024
View
Details
305-769-9
95009-41-9
CCH
Comprehensive
Ongoing
22-Mar-2024
View
Details
700-073-5
1215036-04-6
CCH
Comprehensive
Ongoing
22-Mar-2024
View
Details
806-801-9
1539267-56-5
CCH
Comprehensive
Concluded
22-Mar-2024
View
Details
201-662-5
86-29-3
CCH
Comprehensive
Information requested
23-Jan-2024
22-Mar-2024
View
Details
201-545-9
84-61-7
CCH
Targeted
Information requested
23-Jan-2024
22-Mar-2024
View
Details
229-194-7
6425-39-4
CCH
Comprehensive
Information requested
23-Jan-2024
22-Mar-2024
View
Details
201-353-5
81-48-1
CCH
Comprehensive
Information requested
24-Jan-2024
22-Mar-2024
View
Details
229-059-2
6408-50-0
CCH
Comprehensive
Information requested
24-Jan-2024
22-Mar-2024
View
Details
248-895-9
28198-05-2
CCH
Comprehensive
Information requested
24-Jan-2024
22-Mar-2024
View
Details
445-710-5
108313-21-9
CCH
Comprehensive
Information requested
24-Jan-2024
22-Mar-2024
View
Details
861-799-7
2241885-74-3
TPE
Testing Proposal
Under assessment
22-Mar-2024
Details
249-530-6
29240-17-3
CCH
Comprehensive
Information requested
16-Jan-2024
21-Mar-2024
View
Details
464-700-1
-
CCH
Comprehensive
Information requested
16-Jan-2024
21-Mar-2024
View
Details
215-239-8
1314-62-1
TPE
Testing Proposal
Concluded
21-Mar-2024
View
Details
275-063-2
70955-74-7
CCH
Comprehensive
Information requested
16-Jan-2024
21-Mar-2024
View
Details
247-660-8
26401-35-4
CCH
Comprehensive
Information requested
22-Jan-2024
21-Mar-2024
View
Details
251-646-7
33703-08-1
CCH
Comprehensive
Information requested
22-Jan-2024
21-Mar-2024
View
Details
248-299-9
27178-16-1
CCH
Comprehensive
Information requested
22-Jan-2024
21-Mar-2024
View
Details
287-791-8
85585-89-3
CCH
Comprehensive
Information requested
16-Jan-2024
21-Mar-2024
View
Details
DAROCUR (R) 2959; DAROCUR 2959
402-670-3
106797-53-9
CCH
Comprehensive
Ongoing
21-Mar-2024
View
Details
701-360-8
-
CCH
Comprehensive
Information requested
16-Jan-2024
20-Mar-2024
View
Details
941-533-7
-
CCH
Comprehensive
Information requested
16-Jan-2024
20-Mar-2024
View
Details
247-094-1
25550-51-0
CCH
Comprehensive
Information requested
16-Jan-2024
20-Mar-2024
View
Details
279-015-1
78952-61-1
CCH
Comprehensive
Concluded
16-Jan-2024
20-Mar-2024
View
Details
202-802-8
99-93-4
CCH
Comprehensive
Ongoing
20-Mar-2024
View
Details
225-218-5
4724-48-5
TPE
Testing Proposal
Concluded
19-Mar-2024
View
Details
700-111-0
148528-05-6
CCH
Comprehensive
Concluded
19-Mar-2024
View
Details
413-060-1
134376-16-2
CCH
Comprehensive
Information requested
18-Jan-2024
18-Mar-2024
View
Details
434-280-4
-
CCH
Comprehensive
Information requested
19-Jan-2024
18-Mar-2024
View
Details
204-574-5
122-78-1
CCH
Comprehensive
Information requested
18-Jan-2024
18-Mar-2024
View
Details
207-329-0
462-94-2
CCH
Comprehensive
Ongoing
18-Mar-2024
View
Details
201-188-9
79-24-3
CCH
Targeted
Information requested
19-Jan-2024
18-Mar-2024
View
Details
202-626-1
98-00-0
CCH
Comprehensive
Information requested
19-Jan-2024
18-Mar-2024
View
Details
200-835-2
75-05-8
CCH
Comprehensive
Information requested
18-Jan-2024
18-Mar-2024
View
Details
214-447-6
1129-42-6
TPE
Testing Proposal
Under assessment
18-Mar-2024
View
Details
945-883-1
1379424-11-9
CCH
Comprehensive
Concluded
18-Jan-2024
18-Mar-2024
View
Details
500-107-7
40039-93-8
CCH
Comprehensive
Information requested
18-Jan-2024
18-Mar-2024
View
Details
290-475-2
90170-42-6
TPE
Testing Proposal
15-Mar-2024
View
Details
205-391-3
140-01-2
TPE
Testing Proposal
Under assessment
15-Mar-2024
View
Details
236-882-0
13531-52-7
CCH
Comprehensive
Information requested
10-Nov-2023
15-Mar-2024
View
Details
201-939-0
89-78-1
TPE
Testing Proposal
15-Mar-2024
View
Details
238-510-2
14507-19-8
CCH
Comprehensive
Information requested
09-Nov-2023
15-Mar-2024
View
Details
215-200-5
1312-81-8
CCH
Comprehensive
Information requested
09-Nov-2023
15-Mar-2024
View
Details
214-447-6
1129-42-6
CCH
Comprehensive
Follow-up
07-Dec-2021
15-Mar-2024
View
Details
823-458-0
1631149-46-6
CCH
Comprehensive
Ongoing
15-Mar-2024
View
Details
629-661-9
83834-59-7
TPE
Testing Proposal
Follow-up
07-Sep-2022
15-Mar-2024
View
Details
938-572-7
-
TPE
Testing Proposal
Concluded
10-Feb-2020
14-Mar-2024
View
Details
947-833-4
-
CCH
Comprehensive
Ongoing
14-Mar-2024
View
Details
226-806-4
5471-51-2
CCH
Comprehensive
Ongoing
14-Mar-2024
View
Details
309-798-8
101012-97-9
CCH
Comprehensive
Follow-up
02-Jun-2021
13-Mar-2024
View
Details
231-850-2
7759-02-6
CCH
Comprehensive
Concluded
08-Dec-2020
13-Mar-2024
View
Details
280-445-7
83411-71-6
CCH
Comprehensive
Ongoing
13-Mar-2024
View
Details
442-300-8
-
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
939-595-5
-
CCH
Comprehensive
Information requested
08-Dec-2023
12-Mar-2024
View
Details
915-680-2
-
CCH
Comprehensive
Information requested
08-Dec-2023
12-Mar-2024
View
Details
944-271-1
-
TPE
Testing Proposal
Follow-up
15-Aug-2022
12-Mar-2024
View
Details
243-077-8
19455-20-0
CCH
Comprehensive
Concluded
12-Mar-2024
View
Details
690-526-2
38632-47-2
CCH
Comprehensive
Concluded
12-Mar-2024
View
Details
237-252-8
13709-38-1
CCH
Comprehensive
Information requested
09-Nov-2023
12-Mar-2024
View
Details
233-237-5
10099-58-8
CCH
Comprehensive
Information requested
09-Nov-2023
12-Mar-2024
View
Details
500-130-2
55818-57-0
CCH
Comprehensive
Follow-up
05-Jan-2024
12-Mar-2024
View
Details
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
400-600-6
71868-10-5
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
400-600-6
71868-10-5
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
472-110-0
-
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
444-860-9
474510-57-1
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
CG 25-369; IRGACURE 369; TK 11-319
404-360-3
119313-12-1
CCH
Targeted
Under assessment
12-Mar-2024
View
Details
230-743-8
7299-99-2
CCH
Comprehensive
Follow-up
02-Jun-2021
12-Mar-2024
View
Details
819-558-9
2020359-04-8
CCH
Comprehensive
Under assessment
12-Mar-2024
View
Details
242-582-0
18794-84-8
CCH
Comprehensive
Follow-up
02-Jun-2021
12-Mar-2024
View
Details
205-758-8
150-38-9
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
235-979-5
13078-36-9
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
250-709-6
31570-04-4
CCH
Comprehensive
Information requested
16-Nov-2023
11-Mar-2024
View
Details
250-709-6
31570-04-4
TPE
Testing Proposal
Information requested
16-Nov-2023
11-Mar-2024
View
Details
239-802-2
15708-41-5
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
200-529-9
62-33-9
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
257-036-7
51181-50-1
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
902-532-7
-
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
259-411-0
54959-35-2
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
205-391-3
140-01-2
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
404-290-3
7216-95-7
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
205-759-3
150-39-0
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
936-414-1
-
CCH
Targeted
Information requested
30-Nov-2023
11-Mar-2024
View
Details
227-105-6
5657-17-0
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
239-407-5
15375-84-5
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
238-372-3
14402-88-1
CCH
Targeted
Under assessment
11-Mar-2024
View
Details
247-019-2
25481-21-4
CCH
Targeted
Under assessment
11-Mar-2024
View
Details

Export search results to: